These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 7747839
1. Treating esophageal cancer with a combination of chemotherapy, radiation, and excision. Girvin GW, Matsumoto GH, Bates DM, Garcia JM, Clyde JC, Lin PH. Am J Surg; 1995 May; 169(5):557-9. PubMed ID: 7747839 [Abstract] [Full Text] [Related]
2. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy. Weiner LM, Colarusso P, Goldberg M, Dresler C, Coia LR. Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276 [Abstract] [Full Text] [Related]
3. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP. Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [Abstract] [Full Text] [Related]
4. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. Naunheim KS, Petruska P, Roy TS, Andrus CH, Johnson FE, Schlueter JM, Baue AE. J Thorac Cardiovasc Surg; 1992 May; 103(5):887-93; discussion 893-5. PubMed ID: 1569771 [Abstract] [Full Text] [Related]
8. Optimal treatment for localized esophageal cancer still uncertain. Lord RV. Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607 [Abstract] [Full Text] [Related]
9. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Meluch AA, Hainsworth JD, Gray JR, Thomas M, Whitworth PL, Davis JL, Greco FA. Cancer J Sci Am; 1999 Jan; 5(2):84-91. PubMed ID: 10198730 [Abstract] [Full Text] [Related]
12. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA, Duhaylongsod FG. J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009 [Abstract] [Full Text] [Related]
13. Management for patients with advanced T4 epidermoid carcinoma of the esophagus. Wang LS, Chi KH, Hu MH, Fahn HJ, Huang MH. J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396 [Abstract] [Full Text] [Related]
18. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category. Saha AK, Sutton C, Rotimi O, Dexter S, Sue-Ling H, Sarela AI. Ann Surg Oncol; 2009 May 15; 16(5):1364-70. PubMed ID: 19252949 [Abstract] [Full Text] [Related]
19. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M. Radiology; 1999 Oct 15; 213(1):67-72. PubMed ID: 10540642 [Abstract] [Full Text] [Related]
20. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report. Henry LR, Goldberg M, Scott W, Konski A, Meropol NJ, Freedman G, Weiner LM, Watts P, Beard M, McLaughlin S, Cheng JD. Ann Surg Oncol; 2006 Feb 15; 13(2):214-20. PubMed ID: 16418887 [Abstract] [Full Text] [Related] Page: [Next] [New Search]